BAT test to replace sting challenge in venom allergy care
Part of Immune system & allergy clinical trials.
This study looks at whether a BAT (a blood test) can stand in for sting/venom “challenges” for people already receiving venom immunotherapy. If it works, it could help patients avoid more risky or uncomfortable challenge procedures while still checking whether treatment is working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 70.
- You are being treated with vespid venom immunotherapy now or you have been treated with it before.
- You can legally consent to take part in the study.
- You are not pregnant.
- You do not have an autoimmune disease.
- Your asthma and heart condition are controlled (not “uncontrolled”).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether having strong reactions to a specific bee venom protein can make venom immunotherapy less effective. It may help doctors better predict who is at higher risk for therapy failure after bee stings.
This trial tests a venom immunotherapy for people allergic to bee or wasp stings. It aims to see how well the treatment works in everyday medical practice.
This study tests a treatment called Beltaven® for people with severe allergic reactions to bee, wasp, or hornet stings. It aims to see if the treatment is safe and helps prevent future reactions.
This study looks at how beekeepers develop tolerance to bee venom over time, comparing people who are new to beekeeping, experienced beekeepers without allergies, and beekeepers who have had a recent allergic reaction. If you fall into one of these groups, you may be able to join and help researchers understand how the immune system adapts to bee stings.
This study monitors the safety of venom immunotherapy (allergy shots) for people with bee or wasp sting allergies. If you are starting this treatment, researchers will track how well you tolerate it over time.
This study looks at a type of immune cell (B regulatory cell) in the blood of people with and without allergies to pollens, house dust mites, or insect stings. It aims to help understand how these cells work in allergic disease.
Hear when a new Vespid Venom Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.